A2A Pharmaceuticals
New York
About A2A Pharmaceuticals
A2A Pharmaceuticals Inc. is a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents. Their focus is on the development of novel drugs to treat antibiotic resistant bacterial infections and address unmet needs in cancer. They incorporate computational tools and interdisciplinary ingenuity into the rational design of therapeutics. Their unique computational design platform SCULPT™ integrates experimentally determined target characteristics into the systematic construction of therapeutic candidates.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (Sep 2016)
- Website: a2apharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/a2a-pharmaceuticals-1097527 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.